A Randomized Trial to Evaluate the Sustained Efficacy of a Mucus Clearance Device in Ambulatory Patients with Chronic Obstructive Pulmonary Disease | Zendy

Norman Wolkove | Zendy; Marc Baltzan | Zendy; Hany Kamel | Zendy; Michael Rotaple | Zendy

Open Access

A Randomized Trial to Evaluate the Sustained Efficacy of a Mucus Clearance Device in Ambulatory Patients with Chronic Obstructive Pulmonary Disease

Author(s) -

Norman Wolkove,

Marc Baltzan,

Hany Kamel,

Michael Rotaple

Publication year - 2004

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2004/828591

Subject(s) - medicine , bronchodilator , ipratropium bromide , copd , ambulatory , vital capacity , salbutamol , anesthesia , crossover study , asthma , placebo , lung , diffusing capacity , lung function , alternative medicine , pathology

To determine whether a mucus clearance device (MCD) (Flutter; Axcan Scandipharm, USA) could consistently improve the bronchodilator response and exercise performance in patients with chronic obstructive pulmonary disease (COPD) when used in an ambulatory setting over a one-week period.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research